KR970004035B1 - Dentifrice compositions - Google Patents
Dentifrice compositions Download PDFInfo
- Publication number
- KR970004035B1 KR970004035B1 KR1019910024806A KR910024806A KR970004035B1 KR 970004035 B1 KR970004035 B1 KR 970004035B1 KR 1019910024806 A KR1019910024806 A KR 1019910024806A KR 910024806 A KR910024806 A KR 910024806A KR 970004035 B1 KR970004035 B1 KR 970004035B1
- Authority
- KR
- South Korea
- Prior art keywords
- toothpaste
- oral hygiene
- present
- salt
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 글리코 콜린산(glycocholic acid)과 타우로 콜린산(taurocholic acid)를 함유하는 우담(소쓸개)액과 소금을 혼합 회화시켜 만든 구강위생제를 함유시킴으로써 프라그 제거효과 및 치은염 등 치주질환 예방 및 치료에 유용한 치약 조성물에 관한 것이다.The present invention comprises an oral hygiene agent made by mixing sintered gallcolic acid and salt containing glycocholic acid and taurocholic acid and salt to prevent periodontal disease such as plaque removal effect and gingivitis. And toothpaste compositions useful for treatment.
프라그라 함은 치아표면에 형성되는 세균막으로써 사람이 섭취하는 음식물 찌꺼기와 구강내 존재하는 미생물에 의해 형성되는 끈끈한 고분자량의 물질로서 형성된 것을 말한다. 이러한 프라그를 억제 또는 제거하기 위하여 종래에는 잇솔질과 적당한 연마제를 함유하는 치약을 사용하는 등의 물리적인 방법과 살균제 등을 사용하여 왔으며 최근에는 효소를 이용하여 프라그를 형성하는 중간 단계인 덱스트란과 글루칸이라는 고분자 물질을 분해하는 방법 등이 사용되고 있다. 그러나 효소를 사용하는 경우 효소와 치약 조성물에 일반적으로 사용되는 성분과 상용성이 좋지 않다는 등의 문제점이 있다.Fragra is a bacterial film formed on the surface of the tooth formed as a sticky high molecular weight material formed by food intake and microorganisms present in the mouth. In order to suppress or remove such plaques, conventionally, physical methods such as using toothbrushes containing toothbrushes and appropriate abrasives, and fungicides have been used. Recently, dextran and glucan, which are intermediate stages of forming plaques using enzymes, have been used. The method of decomposing a high molecular material, etc., is used. However, when the enzyme is used, there are problems such as poor compatibility with components generally used in enzymes and toothpaste compositions.
또한 종래에 치주질환 예방제로서는 염화나트륨, 항프라스민제, 알란토인 유도체, 비타민류, 아미노산류 등을 단독 또는 혼합 사용하여 구강위생 증진용 조성물로서 광범위하게 사용되고 있다.In addition, as a preventive agent for periodontal disease, sodium chloride, antifrasminant, allantoin derivatives, vitamins, amino acids, etc. are conventionally used as a composition for enhancing oral hygiene.
본 발명자들은 우담액에는 글리코 콜린산과 타우르 콜린산이 함유되어 있는데 이중 콜린산 성분이 프라그 생성억제 및 치주질환 억제작용을 하며 또한 회화된 소금 성분이 치주질환 완화 작용을 한다는 점에 착안하여, 종래의 치약 조성물에 소금과 우담액을 혼합 회화시켜 만든 구강위생제를 사용한 결과 프라그 제거효과 및 치주질환예방 및 치료효과가 크게 개선된다는 놀라운 사실을 밝혀내고 본 발명을 완성하기에 이르렀다.The present inventors have focused on the fact that the uric acid solution contains glycocholine acid and taurcholine acid, of which the choline acid component inhibits plaque formation and inhibits periodontal disease, and the ingested salt component acts to alleviate periodontal disease. As a result of using oral hygiene made by mixing and mixing salt and biliary juice in the toothpaste composition, it has been surprisingly found that the plaque removal effect and the periodontal disease prevention and treatment effect are greatly improved, thus completing the present invention.
본 발명은 우담(소쓸개)와 소금을 혼합 회화시켜 만든 구강 위생제를 함유함을 특징으로 하는 치약 조성물에 관한 것이다.The present invention relates to a toothpaste composition characterized by containing an oral hygiene agent made by mixing and painting a scavenger (sorcere) and salt.
본 발명의 치약 조성물에는 상기 구강위생제를 0.1 내지 10중량% 함유하는 것이 바람직하다. 구강위생제를 0.1% 이하로 사용하면 그 효과가 대단히 나쁘며 10중량% 이상으로 사용하면 치약의 제조가 어렵다.The toothpaste composition of the present invention preferably contains 0.1 to 10% by weight of the oral hygiene agent. If the oral hygiene is used at less than 0.1%, the effect is very bad, and if used at more than 10% by weight, it is difficult to manufacture toothpaste.
본 발명에서 사용되는 구강위생제는 우담(소쓸개)와 소금을 1 : 3 내지 3 : 1의 비율로 혼합하여 이를 적당한 종이등의 용기에 담아서 진흙 등으로 완전히 밀폐시킨 다음 800℃ 내지 1700℃의 고열로 우담의 지방 및 수분이 완전히 증발될때까지 적당하게 회화시킨 다음, 파쇄하여 만든 연한 갈색의 분말상태의 구강위생제를 말한다. 상기 혼합범위를 벗어나는 경우에는 고온 회화 가열시 파열가능성이 있고 진흙 등으로 밀봉이 불가능하므로 우담염의 제조가 불가능하며 치은염에 대한 효과도 약하다.The oral hygiene agent used in the present invention is mixed with a scavenger (soe gallbladder) and salt in a ratio of 1: 3 to 3: 1 and put it in a container such as a suitable paper and completely sealed with mud, and then the temperature of 800 ℃ to 1700 ℃ It is a light brown powdery oral hygiene product made by ingesting properly and crushing the fat and water of Udam at high heat. If it is out of the mixing range there is a possibility of rupture during high temperature incineration heating and can not be sealed with mud and the like, it is impossible to manufacture milky salt and the effect on gingivitis is weak.
일반적으로 본 발명의 치약 조성물에 사용되는 성분으로는 먼저 연마제를 들 수 있는데, 여기에는 인산일수소칼슘, 침강실리카, 탄산칼슘, 함수 알루미나 등을 사용할 수 있으며, 바람직하게는 인산일수소칼슘, 알루미나 등이며, 그 사용량은 20 내지 50중량%가 바람직하다.In general, the components used in the toothpaste composition of the present invention may include an abrasive, which may include calcium dihydrogen phosphate, precipitated silica, calcium carbonate, hydrous alumina, and the like, and preferably calcium dihydrogen phosphate and alumina. And the amount thereof is preferably 20 to 50% by weight.
또한 사용시 볼륨감을 제공하기 위하여 기포제를 사용하는데, 기포제로는 음이온 계면활성제, 비이온 계면활성제를 사용할 수 있으며 이중에서도 특히 라우릴 황산나트륨 및 폴리옥시에틸렌 폴리옥시프로필렌 공중합체(상품명 플루로닉)를 1 내지 5중량% 사용하는 것이 바람직하다.In addition, a foaming agent is used to provide a sense of volume in use, and as the foaming agent, anionic surfactants and nonionic surfactants may be used, among which sodium lauryl sulfate and polyoxyethylene polyoxypropylene copolymer (trade name Pluronic) are used. It is preferable to use 5 to 5% by weight.
또한 치약 형성제로서 중요한 습윤제로는 글리세린, 폴리에틸렌 글리콜, 소르비톨액, 비결정성 소르비톨 및 말티톨, 자일리톨(Xilitol) 등을 사용할 수 있으며 본 발명에서는 특히 글리세린, 소르비톨액, 비결정성 소르비톨, 자일리톨 등을 10 내지 60중량% 사용하는 것이 바람직하다.In addition, humectants which are important as toothpaste formers may be glycerin, polyethylene glycol, sorbitol liquid, amorphous sorbitol and maltitol, xylitol, and the like. It is preferable to use 60 weight%.
치약을 적당한 페이스트 상태로 유지시켜 주고 분말성분인 연마제 등의 고체성분과 액체성분을 적당한 분산상으로 만들어 주기 위하여 사용되는 결합제는 카르복시메틸 셀룰로오즈 나트륨, 잔탄검, 카라기난, 카포폴 등을 단독 또는 혼합하여 0.1 내지 10중량%, 바람직하게는 0.5 내지 5중량% 사용한다.The binder used to keep the toothpaste in the proper paste state and to make the solid and liquid components such as powder abrasives into the proper disperse phase is mixed with carboxymethyl cellulose sodium, xanthan gum, carrageenan, capopol and the like by 0.1 To 10% by weight, preferably 0.5 to 5% by weight.
본 발명에서는 이밖에도 향료, 색상의 조화를 위한 색소, 방부제, 감미제 등을 적당량 사용할 수 있다.In the present invention, a suitable amount of fragrances, pigments for color harmony, preservatives, sweeteners and the like can be used.
이하, 본 발명의 치약 조성물(실시예 1 내지 5)과 종래의 치약 조성물(비교예 1 내지 3)의 구성분과 그 사용량을 요약하여 설명하면 다음 표 1과 같다.Hereinafter, the components of the toothpaste compositions (Examples 1 to 5) and the conventional toothpaste compositions (Comparative Examples 1 to 3) of the present invention will be summarized as follows.
[표 1]TABLE 1
실혐예 1Example 1
프라그 생성 억제율 측정시험Plaque generation inhibition test
본 발명에 의한 치약 조성물의 프라그 생성 억제율을 측정하기 위하여 종래의 치약과 비교하여 총 40명의 성인을 8개군의 시험대상으로 나누어 2주간 사용케한 다음 양치방법으로 양치한 후 프라그 Index를 측정하여 억제율을 측정한 결과, 본 발명에 의한 치약 조성물의 프라그 생성 억제율이 35 내지 43%로써 종래 치약의 9 내지 12%보다 월등하게 우수한 것으로 나타났다.In order to measure the plaque production inhibition rate of the toothpaste composition according to the present invention, compared to the conventional toothpaste, a total of 40 adults were divided into 8 groups of test subjects for 2 weeks and then brushed by the brushing method, and then the plaque index was measured. As a result of the measurement, the plaque production inhibition rate of the toothpaste composition according to the present invention was 35 to 43%, which was superior to 9 to 12% of the conventional toothpaste.
실험예 2Experimental Example 2
실시예 1 내지 5와 비교예 1 내지 3의 치주질환 예방효과 비교실험Comparative experiment of the periodontal disease prevention effect of Examples 1 to 5 and Comparative Examples 1 to 3
본 발명 치약과 비교예 치약을 가지고 매일 3회씩(각 3분간) 20일간 양치질을 하게 하고 20일 후 잇몸의 색상변화를 측정하여 잇몸의 건강상태 유지 및 개선효과를 비교 시험하였다. 색상변화는 일본전색의 ∑80 색차계(colorimeter)를 사용하였다.The toothpaste of the present invention and the comparative example toothpaste was brushed three times daily (for 3 minutes each) for 20 days, and after 20 days, the color change of the gum was measured to compare and maintain the health condition and improvement effect of the gums. Color change was performed using a Japanese color? 80 colorimeter.
[표 2]TABLE 2
(* 수치는 각 그룹의 평균치임)(* Figures are averages for each group)
L : 명도지수 a : 적색도(+), 녹색도(-)L: Brightness Index a: Redness (+), Greenness (-)
b : 황색도(+), 청색도(-)b: yellow degree (+), blue degree (-)
** 건강한 잇몸일수록 명도지수가 크고 적색도가 높으면 황색도는 낮게 나타난 선명한 홍색을 나타낸다.** The more healthy gums, the brighter the index and the higher the redness, the lower the yellowness.
[표 3] 평균 변화값[Table 3] Average change value
상기 표에서와 같이 본 발명에 의한 치약 조성물을 사용한 실시예 1 내지 5그룹에서 명도지수(L)와 적색도(a)가 종래의 비교예 보다 월등히 향상됨은 물론 잇몸의 건강에도 좋은 것으로 나타났다.As shown in the above table, in Examples 1 to 5 using the toothpaste composition according to the present invention, the brightness index (L) and the redness (a) were significantly improved as compared with the conventional comparative example, as well as the health of the gums.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019910024806A KR970004035B1 (en) | 1991-12-28 | 1991-12-28 | Dentifrice compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019910024806A KR970004035B1 (en) | 1991-12-28 | 1991-12-28 | Dentifrice compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
KR930011993A KR930011993A (en) | 1993-07-20 |
KR970004035B1 true KR970004035B1 (en) | 1997-03-24 |
Family
ID=19326367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910024806A KR970004035B1 (en) | 1991-12-28 | 1991-12-28 | Dentifrice compositions |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970004035B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000041605A1 (en) | 1999-01-16 | 2000-07-20 | Jong Do Peter Park | Cooking utensil |
WO2000041604A1 (en) | 1999-01-16 | 2000-07-20 | Jong Do Peter Park | Cooking utensil and manufacturing method therefor |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100453351B1 (en) * | 1996-07-25 | 2005-04-19 | 주식회사 엘지생활건강 | Oral Hygiene Composition |
-
1991
- 1991-12-28 KR KR1019910024806A patent/KR970004035B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000041605A1 (en) | 1999-01-16 | 2000-07-20 | Jong Do Peter Park | Cooking utensil |
WO2000041604A1 (en) | 1999-01-16 | 2000-07-20 | Jong Do Peter Park | Cooking utensil and manufacturing method therefor |
Also Published As
Publication number | Publication date |
---|---|
KR930011993A (en) | 1993-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3962417A (en) | Dentifrice | |
US4652444A (en) | Methods and compositions for treating dental structures | |
EP0273579B1 (en) | A composition for periodontal use | |
US4708864A (en) | Method and compositions for treating dental structures | |
US4976954A (en) | Anticariogenic compositions | |
JPH06502141A (en) | mouth rinse | |
KR101992927B1 (en) | Toothpaste composition for prevention and improvement of periodontal disease | |
JP2001500874A (en) | Mouthwash consisting of calcium and phosphate ions in supersaturated solution | |
CN107485575A (en) | A kind of toothpaste of oral cavity helicobacter pylori resistant and anti-caries stomach strengthening function and preparation method thereof | |
US4863722A (en) | Dentifrice compositions | |
JPH07503948A (en) | Oral hygiene methods and compositions | |
KR970004035B1 (en) | Dentifrice compositions | |
CN114272196A (en) | Composition for regulating oral flora balance, preparation method and application thereof | |
US3894147A (en) | Method and composition for inhibiting calculus | |
CN108670872A (en) | Tasty and refreshing gas toothpaste | |
CN113081893A (en) | Oral bacteriostatic composition, preparation method and application thereof | |
CN108125815A (en) | A kind of toothpaste of oral cavity helicobacter pylori resistant and anti-caries stomach strengthening function and preparation method thereof | |
CN106265327B (en) | Oral care composition | |
CN115645291A (en) | Zeolite toothpaste | |
JP2007131601A (en) | Composition for oral cavity | |
JPH0495020A (en) | Enzyme inhibitor | |
JPH08245353A (en) | Oral cavity composition | |
EP0267994B1 (en) | The use of a metal complex for the manufacture of a composition for treating dental structures | |
US20220354774A1 (en) | Toothpaste for preventing cold teeth and periodontal diseases and manufacturing method therefor | |
JP3793625B2 (en) | Powder dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20071108 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |